Biochemical characterisation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from the liver fluke, Fasciola hepatica

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 4, 2014, Pages 744-749

  Zinsser, Veronika L ^a   Hoey, Elizabeth M ^a   Trudgett, Alan ^a   Timson, David J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Drug target; G3PDH; Glycolytic enzyme; Neglected tropical disease; Trematode; Vaccine target

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTITRYPANOSOMAL AGENT; DIMER; GLYCERALDEHYDE 3 PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HOMODIMER; NICOTINAMIDE ADENINE DINUCLEOTIDE; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TETRAMER;

AMINO ACID SEQUENCE; ARTICLE; ENZYME CONFORMATION; ENZYME STRUCTURE; ESCHERICHIA COLI; FASCIOLA HEPATICA; FLUOROMETRY; GEL FILTRATION; ISOELECTRIC POINT; LIGAND BINDING; MICHAELIS MENTEN KINETICS; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; TREMATODE;

DRUG TARGET; G3PDH; GLYCOLYTIC ENZYME; NEGLECTED TROPICAL DISEASE; TREMATODE; VACCINE TARGET;

ANIMALS; BIOCATALYSIS; ESCHERICHIA COLI; FASCIOLA HEPATICA; FLUOROMETRY; GLYCERALDEHYDE 3-PHOSPHATE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HELMINTH PROTEINS; HUMANS; KINETICS; MODELS, MOLECULAR; NAD; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; RECOMBINANT FUSION PROTEINS;

EID: 84896769184     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.02.008     Document Type: Article

References (60)

1. V. Srinivasan, and H.J. Morowitz Ancient genes in contemporary persistent microbial pathogens Biol. Bull. 210 2006 1 9
2. M.W. Robinson, and J.P. Dalton Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases Phil. Trans. R. Soc. Lond. B Biol. Sci. 364 2009 2763 2776
3. J.C. Boray Diseases of Domestic Animals Caused by Flukes 1994 Food and Agricultural Organisation of the United Nations Rome
4. G.P. Brennan, I. Fairweather, A. Trudgett, E. Hoey, McCoy, M. McConville, M. Meaney, M. Robinson, N. McFerran, L. Ryan, C. Lanusse, L. Mottier, L. Alvarez, H. Solana, G. Virkel, and P.M. Brophy Understanding triclabendazole resistance Exp. Mol. Pathol. 82 2007 104 109
5. J. Canevari, L. Ceballos, R. Sanabria, J. Romero, F. Olaechea, P. Ortiz, M. Cabrera, V. Gayo, I. Fairweather, C. Lanusse, and L. Alvarez Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom J. Helminthol. 2013 1 7
6. R. Sanabria, L. Ceballos, L. Moreno, J. Romero, C. Lanusse, and L. Alvarez Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole Vet. Parasitol. 193 2013 105 110
7. S. Mas-Coma, M.A. Valero, and M.D. Bargues Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis Vet. Parasitol. 163 2009 264 280
8. N.J. Fox, P.C. White, C.J. McClean, G. Marion, A. Evans, and M.R. Hutchings Predicting impacts of climate change on Fasciola hepatica risk PLoS One 6 2011 e16126
9. A.M. Aronov, S. Suresh, F.S. Buckner, W.C. Van Voorhis, C.L. Verlinde, F.R. Opperdoes, W.G. Hol, and M.H. Gelb Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase Proc. Natl. Acad. Sci. U. S. A. 96 1999 4273 4278
10. F.A. Soares, R. Sesti-Costa, J.S. da Silva, M.C. de Souza, V.F. Ferreira, C. Santos Fda, P.A. Monteiro, A. Leitao, and C.A. Montanari Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity Bioorg. Med. Chem. Lett. 23 2013 4597 4601
11. J. Bero, C. Beaufay, V. Hannaert, M.F. Herent, P.A. Michels, and J. Quetin-Leclercq Antitrypanosomal compounds from the essential oil and extracts of Keetia leucantha leaves with inhibitor activity on Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase Phytomedicine 20 2013 270 274
12. S. Ganapathy-Kanniappan, R. Kunjithapatham, and J.F. Geschwind Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting Anticancer Res. 33 2013 13 20
13. S. Ganapathy-Kanniappan, J.F. Geschwind, R. Kunjithapatham, M. Buijs, J.A. Vossen, I. Tchernyshyov, R.N. Cole, L.H. Syed, P.P. Rao, S. Ota, and M. Vali Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death Anticancer Res. 29 2009 4909 4918
14. P. Dell'Antone Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent Med. Chem. 5 2009 491 496
15. K. Dalziel, N.V. McFerran, and A.J. Wonacott Glyceraldehyde-3-phosphate dehydrogenase Philos. Trans. R. Soc. Lond. B Biol. Sci. 293 1981 105 118
16. N.K. Nagradova Study of the properties of phosphorylating d-glyceraldehyde-3-phosphate dehydrogenase Biochemistry (Mosc) 66 2001 1067 1076
17. F. Ferreira-da-Silva, P.J. Pereira, L. Gales, M. Roessle, D.I. Svergun, P. Moradas-Ferreira, and A.M. Damas The crystal and solution structures of glyceraldehyde-3-phosphate dehydrogenase reveal different quaternary structures J. Biol. Chem. 281 2006 33433 33440
18. G.W. Carlile, R.M. Chalmers-Redman, N.A. Tatton, A. Pong, K.E. Borden, and W.G. Tatton Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer Mol. Pharmacol. 57 2000 2 12
19. L.I. Ashmarina, V.I. Muronetz, and N.K. Nagradova Immobilized d-glyceraldehyde-3-phosphate dehydrogenase can exist as a trimer FEBS Lett. 128 1981 22 26
20. R.A. Cook, and D.E. Koshland Jr. Positive and negative cooperativity in yeast glyceraldehyde 3-phosphate dehydrogenase Biochemistry 9 1970 3337 3342
21. H.L. Segal, and P.D. Boyer The role of sulfhydryl groups in the activity of d-glyceraldehyde 3-phosphate dehydrogenase J. Biol. Chem. 204 1953 265 281
22. C.S. Wang, and P. Alaupovic Glyceraldehyde-3-phosphate dehydrogenase from human erythrocyte membranes. Kinetic mechanism and competitive substrate inhibition by glyceraldehyde 3-phosphate Arch. Biochem. Biophys. 205 1980 136 145
23. M. Buehner, G.C. Ford, K.W. Olsen, D. Moras, and M.G. Rossman Three-dimensional structure of d-glyceraldehyde-3-phosphate dehydrogenase J. Mol. Biol. 90 1974 25 49
24. M.A. Sirover On the functional diversity of glyceraldehyde-3-phosphate dehydrogenase: biochemical mechanisms and regulatory control Biochim. Biophys. Acta 1810 2011 741 751
25. L. Egea, L. Aguilera, R. Gimenez, M.A. Sorolla, J. Aguilar, J. Badia, and L. Baldoma Role of secreted glyceraldehyde-3-phosphate dehydrogenase in the infection mechanism of enterohemorrhagic and enteropathogenic Escherichia coli: interaction of the extracellular enzyme with human plasminogen and fibrinogen Int. J. Biochem. Cell Biol. 39 2007 1190 1203
26. S.K. Matta, S. Agarwal, and R. Bhatnagar Surface localized and extracellular glyceraldehyde-3-phosphate dehydrogenase of Bacillus anthracis is a plasminogen binding protein Biochim. Biophys. Acta 1804 2010 2111 2120
27. A. Lama, A. Kucknoor, V. Mundodi, and J.F. Alderete Glyceraldehyde-3- phosphate dehydrogenase is a surface-associated, fibronectin-binding protein of Trichomonas vaginalis Infect. Immun. 77 2009 2703 2711
28. S. Charrier-Ferrara, D. Caillol, and V. Goudot-Crozel Complete sequence of the Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase gene encoding a major surface antigen Mol. Biochem. Parasitol. 56 1992 339 343
29. F. Liu, S.J. Cui, W. Hu, Z. Feng, Z.Q. Wang, and Z.G. Han Excretory/secretory proteome of the adult developmental stage of human blood fluke, Schistosoma japonicum Mol. Cell. Proteomics 8 2009 1236 1251
30. R.M. Morphew, H.A. Wright, E.J. LaCourse, D.J. Woods, and P.M. Brophy Comparative proteomics of excretory-secretory proteins released by the liver fluke Fasciola hepatica in sheep host bile and during in vitro culture ex host Mol. Cell. Proteomics 6 2007 963 972
31. A. Ramajo-Hernandez, R. Perez-Sanchez, V. Ramajo-Martin, and A. Oleaga Schistosoma bovis: plasminogen binding in adults and the identification of plasminogen-binding proteins from the worm tegument Exp. Parasitol. 115 2007 83 91
32. R. El Ridi, and H. Tallima Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines J. Parasitol. 99 2013 194 202
33. R. El Ridi, M. Montash, and H. Tallima Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase Scand. J. Immunol. 60 2004 392 402
34. P. Veprek, J. Jezek, J. Velek, H. Tallima, M. Montash, and R. El Ridi Peptides and multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase: preparation, immunogenicity and immunoprotective capacity in C57BL/6 mice J. Pept. Sci. 10 2004 350 362
35. H. Tallima, M. Montash, P. Veprek, J. Velek, J. Jezek, and R. El Ridi Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase Vaccine 21 2003 3290 3300
36. L.L. Argiro, S.S. Kohlstadt, S.S. Henri, H.H. Dessein, V.V. Matabiau, P.P. Paris, A.A. Bourgois, and A.J. Dessein Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH Vaccine 18 2000 2039 2048
37. K. Han, L. Xu, R. Yan, X. Song, and X. Li Vaccination of goats with glyceraldehyde-3-phosphate dehydrogenase DNA vaccine induced partial protection against Haemonchus contortus Vet. Immunol. Immunopathol. 149 2012 177 185
38. V.L. Zinsser, E.M. Hoey, A. Trudgett, and D.J. Timson Biochemical characterisation of triose phosphate isomerase from the liver fluke Fasciola hepatica Biochimie 95 2013 2182 2189
39. M.A. Larkin, G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. Valentin, I.M. Wallace, A. Wilm, R. Lopez, J.D. Thompson, T.J. Gibson, and D.G. Higgins Clustal W and Clustal X version 2.0 Bioinformatics 23 2007 2947 2948
40. D.T. Jones, W.R. Taylor, and J.M. Thornton The rapid generation of mutation data matrices from protein sequences Comput. Appl. Biosci. 8 1992 275 282
41. S. Kumar, M. Nei, J. Dudley, and K. Tamura MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences Brief. Bioinform. 9 2008 299 306
42. K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods Mol. Biol. Evol. 28 2011 2731 2739
43. E. Gasteiger, C. Hoogland, A. Gattiker, S. Duvaud, M.R. Wilkins, R.D. Appel, and A. Bairoch Protein identification and analysis tools on the ExPASy server J.M. Walker, The Proteomics Protocols Handbook 2005 Humana Press New York, USA 571 607
44. L.A. Kelley, and M.J. Sternberg Protein structure prediction on the Web: a case study using the Phyre server Nat. Protoc. 4 2009 363 371
45. S.A. Ismail, and H.W. Park Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase Acta Crystallogr. D Biol. Crystallogr. 61 2005 1508 1513
46. E. Krieger, K. Joo, J. Lee, J. Lee, S. Raman, J. Thompson, M. Tyka, D. Baker, and K. Karplus Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8 Proteins 77 Suppl. 9 2009 114 122
47. R.A. Durst, and B.R. Staples Tris/Tris-HCl: a standard buffer for use in the physiologic pH range Clin. Chem. 18 1972 206 208
48. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
49. T.J. McCorvie, Y. Liu, A. Frazer, T.J. Gleason, J.L. Fridovich-Keil, and D.J. Timson Altered cofactor binding affects stability and activity of human UDP-galactose 4′-epimerase: implications for type III galactosemia Biochim. Biophys. Acta 1822 2012 1516 1526
50. E.G. Krebs, and V.A. Najjar Immunochemical studies on purified d-glyceraldehyde-3-phosphate dehydrogenase from yeast and rabbit muscle Fed. Proc. 7 1948 166
51. J.L. Jenkins, and J.J. Tanner High-resolution structure of human d-glyceraldehyde-3-phosphate dehydrogenase Acta Crystallogr. D Biol. Crystallogr. 62 2006 290 301
52. J.F. Satchell, R.L. Malby, C.S. Luo, A. Adisa, A.E. Alpyurek, N. Klonis, B.J. Smith, L. Tilley, and P.M. Colman Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum Acta Crystallogr. D Biol. Crystallogr. 61 2005 1213 1221
53. F.M. Vellieux, J. Hajdu, C.L. Verlinde, H. Groendijk, R.J. Read, T.J. Greenhough, J.W. Campbell, K.H. Kalk, J.A. Littlechild, and H.C. Watson Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data Proc. Natl. Acad. Sci. U. S. A. 90 1993 2355 2359
54. C.L. Verlinde, M. Callens, S. Van Calenbergh, A. Van Aerschot, P. Herdewijn, V. Hannaert, P.A. Michels, F.R. Opperdoes, and W.G. Hol Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: toward new drugs for the treatment of sleeping sickness J. Med. Chem. 37 1994 3605 3613
55. V.D. Hoagland Jr., and D.C. Teller Influence of substrates on the dissociation of rabbit muscle d-glyceraldehyde 3-phosphate dehydrogenase Biochemistry 8 1969 594 602
56. S. Lakatos, and P. Zavodsky The effect of substrates on the association equilibrium of mammalian d-glyceraldehyde 3-phosphate dehydrogenase FEBS Lett. 63 1976 145 148
57. H.H. Osborne, and M.R. Hollaway An investigation of the nicotinamide-adenine dinucleotide-induced 'tightening' of the structure of glyceraldehyde 3-phosphate dehydrogenase Biochem. J. 157 1976 255 259
58. N.W. Seidler, and G.S. Yeargans Effects of thermal denaturation on protein glycation Life Sci. 70 2002 1789 1799
59. N.W. Seidler Dynamic oligomeric properties Adv. Exp. Med. Biol. 985 2013 207 247
60. T.J. McCorvie, T.J. Gleason, J.L. Fridovich-Keil, and D.J. Timson Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia Biochim. Biophys. Acta 1832 2013 1279 1293